BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van den Brink W, Emerenciana A, Bellanti F, Della Pasqua O, van der Laan JW. Prediction of thyroid C-cell carcinogenicity after chronic administration of GLP1-R agonists in rodents. Toxicol Appl Pharmacol 2017;320:51-9. [PMID: 28213092 DOI: 10.1016/j.taap.2017.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X, Liu J. Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials. Front Endocrinol 2022;13:927859. [DOI: 10.3389/fendo.2022.927859] [Reference Citation Analysis]
2 van der Laan JW, Duijndam B, van den Hoorn T, Woutersen R, van de Water B. Changing the field of carcinogenicity testing of human pharmaceuticals by emphasizing mode of action. Current Opinion in Toxicology 2017;3:55-61. [DOI: 10.1016/j.cotox.2017.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Ahmad E, Sargeant JA, Zaccardi F, Khunti K, Webb DR, Davies MJ. Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes? Pharmaceuticals (Basel) 2020;13:E427. [PMID: 33261058 DOI: 10.3390/ph13120427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lin C, Cai X, Yang W, Lv F, Nie L, Ji L. The Body Weight Alteration and Incidence of Neoplasm in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Front Endocrinol (Lausanne) 2020;11:541699. [PMID: 33424764 DOI: 10.3389/fendo.2020.541699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 van den Brink WJ, Palic S, Köhler I, de Lange ECM. Access to the CNS: Biomarker Strategies for Dopaminergic Treatments. Pharm Res 2018;35:64. [PMID: 29450650 DOI: 10.1007/s11095-017-2333-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]